Blueprint Medicines (BPMC) Inventory Turnover Ratio, from first quarter 2025 to first quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Blueprint Medicines Corporation  (NASDAQ: BPMC)
 

Blueprint Medicines Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Blueprint Medicines Corporation inventory turnover ratio, the Blueprint Medicines Corporation's ability to sell and replace its inventory in the first quarter 2025, sequentially increased to 1.47 in the first quarter 2025, a new company high. Average inventory processing period, for the Blueprint Medicines in Mar 31 2025 quarter, has decreased to 248 days, compare to 326 days, in the Dec 31 2024 quarter.

Within Healthcare sector 280 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 503 in the fourth quarter 2024, to 505.

BPMC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Blueprint Medicines Corporation Market Share?

What is Inventory Turnover Ratio?




BPMC Inventory Turnover Ratio (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Inventory Growth -58.14 % -35.87 % -23.87 % -13.09 % 76.59 %
Y / Y Cost of Sales Growth -12.19 % 2764.23 % -30.55 % 226.86 % 0.5 %
Inventory Turnover Ratio (TTM) 1.47 1.12 0.65 0.66 0.4
BPMC's Total Ranking # 505 # 503 # 445 # 300 # 231
Average inventory processing period 249 325 559 550 913
Seq. Inventory Growth -4.83 % 8.64 % -15.29 % -52.2 % 45.79 %
Seq. Cost of Sales Growth -62.37 % 285.46 % -74.56 % 137.95 % 1127.31 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 83
Healthcare Sector # 281
Overall Market # 505

Inventory Turnover Ratio Statistics
High Average Low
1.47 0.68 0.06
(Mar 31 2025)   (Mar 31 2021)




Financial Statements
Blueprint Medicines's Inventories $ 13 Millions Visit BPMC's Balance sheet
Blueprint Medicines's Cost of Revenues TTM $ 20 Millions Visit BPMC's Income Statement
What are BPMC's Sales? Visit BPMC's Sales by Segment

Other Inventory Turnover Ratios
Blueprint Medicines's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BPMC's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BPMC's Competitors
Inventory Turnover Ratio for BPMC's Suppliers
Inventory Turnover Ratio for BPMC's Customers

You may also want to know
BPMC's Sales Growth Rates BPMC's Pe Price to earnings ratio BPMC's Receivables Turnover Ratio BPMC's Stock Quote
BPMC's Net Income Growth Rates BPMC's Ps Price to Sales ratio BPMC's Sales per Employee BPMC's Asset Turnover Ratio
BPMC's Net Margin BPMC's Pb Price to Book ratio BPMC's Financial Strength Ratios BPMC's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2025 Inventories at quarter ending Mar 31 2025
Logicmark Inc  4.19 $ 3.389  Millions$ 1  Millions
Transmedics Group Inc   4.15 $ 197.880  Millions$ 48  Millions
Escalon Medical Corp   4.12 $ 7.089  Millions$ 2  Millions
Teva Pharmaceutical Industries Limited  4.09 $ 8,447.000  Millions$ 2,065  Millions
Organogenesis Holdings Inc   4.08 $ 111.641  Millions$ 27  Millions
Koru Medical Systems Inc   4.07 $ 12.809  Millions$ 3  Millions
Medinotec Inc   4.06 $ 4.142  Millions$ 1  Millions
Precision Optics Corporation Inc   4.04 $ 13.996  Millions$ 3  Millions
Vericel Corporation  4.02 $ 65.515  Millions$ 16  Millions
Ge Healthcare Technologies Inc   4.01 $ 8,267.000  Millions$ 2,061  Millions
Mirum Pharmaceuticals Inc   4.00 $ 86.831  Millions$ 22  Millions
Safe Pro Group Inc   3.97 $ 1.386  Millions$ 0  Millions
Icad Inc  3.97 $ 2.818  Millions$ 1  Millions
Idexx Laboratories Inc  3.94 $ 1,524.890  Millions$ 387  Millions
Cannapharmarx Inc   3.90 $ 4.301  Millions$ 1  Millions
Edap Tms Sa  3.89 $ 50.339  Millions$ 13  Millions
Abbvie Inc   3.87 $ 16,812.000  Millions$ 4,344  Millions
Harvard Apparatus Regenerative Technology Inc   3.87 $ 0.291  Millions$ 0  Millions
Phathom Pharmaceuticals Inc   3.87 $ 11.271  Millions$ 3  Millions
Electromed Inc   3.86 $ 13.336  Millions$ 3  Millions
Catalyst Pharmaceuticals Inc   3.84 $ 74.236  Millions$ 19  Millions
Dynatronics Corporation  3.82 $ 22.013  Millions$ 6  Millions
Tactile Systems Technology Inc   3.82 $ 74.000  Millions$ 19  Millions
3m Company  3.69 $ 14,440.000  Millions$ 3,917  Millions
Novocure Limited  3.69 $ 142.013  Millions$ 39  Millions
Celularity Inc   3.66 $ 16.903  Millions$ 5  Millions
Iovance Biotherapeutics inc   3.63 $ 166.475  Millions$ 46  Millions
Alpha Teknova Inc   3.62 $ 29.000  Millions$ 8  Millions
Rigel Pharmaceuticals Inc  3.58 $ 21.031  Millions$ 6  Millions
Dih Holding Us Inc   3.57 $ 30.000  Millions$ 8  Millions

Date modified: 2026-08-29T17:30:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.